Nurix Therapeutics Files Q1 2025 10-Q
Ticker: NRIX · Form: 10-Q · Filed: Apr 8, 2025 · CIK: 1549595
Sentiment: neutral
Topics: 10-Q, quarterly-report, biotech
TL;DR
Nurix Q1 2025 10-Q filed. Financials and ops update.
AI Summary
Nurix Therapeutics, Inc. filed a 10-Q for the period ending February 28, 2025. The filing covers the first quarter of their fiscal year. Key financial data and operational details for this period are presented, including comparative figures from the prior year's quarter.
Why It Matters
This filing provides investors with an update on Nurix's financial health and operational progress during the first quarter of fiscal year 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a biopharmaceutical company, Nurix Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-02-28 — Reporting Period End Date (Indicates the end of the fiscal quarter covered by the report.)
- 2025-04-08 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 2024-12-01 — Current Quarter Start Date (Marks the beginning of the fiscal quarter being reported.)
- 2023-12-01 — Prior Year Quarter Start Date (Marks the beginning of the comparable fiscal quarter in the previous year.)
- 1130 — Fiscal Year End (Indicates the company's fiscal year concludes on November 30th.)
Key Players & Entities
- Nurix Therapeutics, Inc. (company) — Filer of the 10-Q
- 20250228 (date) — End of the reporting period
- 20250408 (date) — Filing date
- 2024-12-01 (date) — Start of the current reporting period
- 2023-12-01 (date) — Start of the prior year's comparable period
FAQ
What is the specific reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended February 28, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on April 8, 2025.
What is Nurix Therapeutics, Inc.'s fiscal year end?
Nurix Therapeutics, Inc.'s fiscal year ends on November 30.
What was the start date of the comparable prior year period?
The start date of the comparable prior year period was December 1, 2023.
What is the Standard Industrial Classification (SIC) code for Nurix Therapeutics, Inc.?
The SIC code for Nurix Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 8, 2025 regarding Nurix Therapeutics, Inc. (NRIX).